A very effective treatment for neovascular macular degeneration

Editorial

Edwin M Stone. N Engl J Med. 2006.

. 2006 Oct 5;355(14):1493-5.

doi: 10.1056/NEJMe068191.

No abstract available

Comment on

Ranibizumab for neovascular age-related macular degeneration.
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY; MARINA Study Group. Rosenfeld PJ, et al. N Engl J Med. 2006 Oct 5;355(14):1419-31. doi: 10.1056/NEJMoa054481. N Engl J Med. 2006. PMID: 17021318 Clinical Trial.
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S; ANCHOR Study Group. Brown DM, et al. N Engl J Med. 2006 Oct 5;355(14):1432-44. doi: 10.1056/NEJMoa062655. N Engl J Med. 2006. PMID: 17021319 Clinical Trial.
Age-related macular degeneration.
de Jong PT. de Jong PT. N Engl J Med. 2006 Oct 5;355(14):1474-85. doi: 10.1056/NEJMra062326. N Engl J Med. 2006. PMID: 17021323 Review. No abstract available.